Aberdeen Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-609,351
| Closed | -$17.4M | – | 955 |
|
|
2024
Q2 | $17.4M | Buy |
609,351
+64,433
| +12% | +$1.84M | 0.03% | 407 |
|
|
2024
Q1 | $15.9M | Buy |
544,918
+96,227
| +21% | +$2.81M | 0.03% | 460 |
|
|
2023
Q4 | $15.1M | Buy |
448,691
+56,081
| +14% | +$1.89M | 0.03% | 456 |
|
|
2023
Q3 | $12M | Sell |
392,610
-83,811
| -18% | -$2.57M | 0.03% | 414 |
|
|
2023
Q2 | $19.1M | Buy |
+476,421
| New | +$19.1M | 0.04% | 352 |
|